Luis Martinez-Sobrido

This inventor holds 13 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignees: University of Rochester, Cornell University, Scripps Research Institute. Active years: 2018-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Luis Martinez-Sobrido. Retrieved from https://idiyas.com/inventor/luis-martinez-sobrido

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 13 (Patent Applications = 3)

% Patents Active = 100.0

EPO Patents = 1 (Patent Applications = 9)

Average Co-Inventor Count = 2.6

ph-index = 1

Forward Citations = 6(Granted Patents)

Location History:

San Antonio, TX (US) (2023)
Rochester, NY (US) (2018 - 2024)

Company Filing History:

13 out of 994

University of Rochester

Scripps Research Institute

patents

4. 1 out of 903

University of Kentucky Research Foundation

where one patent can have more than one assignee

Years Active: 2018-2026

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12516108 - MONOCLONAL ANTIBODIES AGAINST THE HEMAGGLUTININ (HA) AND NEURAMINIDASE (NA) OF INFLUENZA H3N2 VIRUSES (2026-01-06),

2. 12421301 - Anti-influenza neuraminidase monoclonal antibodies and uses thereof (2025-09-23),

3. 12350328 - Multivalent live-attenuated influenza vaccine for prevention and control of equine influenza virus (EIV) in horses (2025-07-08),

4. 11958895 - Anti-influenza neuraminidase monoclonal antibodies and uses thereof (2024-04-16),

5. 11576963 - Multivalent live-attenuated influenza vaccine for prevention and control of equine influenza virus (EIV) in horses (2023-02-14),

6. 11168129 - Broadly neutralizing anti-influenza human monoclonal antibody and uses thereof (2021-11-09),

7. 11065326 - Live-attenuated vaccine having mutations in viral polymerase for the treatment and prevention of canine influenza virus (2021-07-20),

8. 10973903 - NS1 truncated virus for the development of canine influenza vaccines (2021-04-13),

9. 10857224 - Equine influenza virus live attenuated vaccines (2020-12-08),

10. 10548966 - Single-cycle virus for the development of canine influenza vaccines (2020-02-04),

11. 10478489 - Live-attenuated vaccine having mutations in viral polymerase for the treatment and prevention of canine influenza virus (2019-11-19),

12. 10342861 - Arenavirus vaccine (2019-07-09),

13. 9943585 - Methods and compositions related to reorganization of arenavirus genome for development of novel arenavirus live-attenuated vaccines (LAV) (2018-04-17),

Title: The Innovative Contributions of Luis Martinez-Sobrido

Introduction

Luis Martinez-Sobrido is a prominent inventor based in Rochester, NY, known for his significant contributions to the field of virology and vaccine development. With a total of 12 patents to his name, he has made remarkable strides in the fight against influenza and other viral infections. His work is characterized by a commitment to advancing medical science and improving public health.

Latest Patents

Among his latest patents, one notable invention is the "Anti-influenza neuraminidase monoclonal antibodies and uses thereof." This invention relates to broadly neutralizing anti-influenza monoclonal antibodies or antigen-binding fragments, which have therapeutic applications. Another significant patent is the "Multivalent live-attenuated influenza vaccine for prevention and control of equine influenza virus (EIV) in horses." This invention provides compositions and methods for equine live-attenuated influenza vaccines, showcasing his innovative approach to veterinary medicine.

Career Highlights

Luis has worked with esteemed institutions such as the University of Rochester and Cornell University. His research has focused on developing effective vaccines and treatments for influenza, contributing to both human and animal health. His dedication to scientific research has positioned him as a leader in his field.

Collaborations

Throughout his career, Luis has collaborated with notable colleagues, including Aitor Nogales-Gonzalez and Colin Parrish. These partnerships have enhanced his research efforts and expanded the impact of his inventions.

Conclusion

Luis Martinez-Sobrido's innovative work in the field of virology and vaccine development has made a significant impact on public health. His contributions continue to advance our understanding and treatment of viral infections, particularly influenza.

Profile summary based on public USPTO records.